Sleep-hygiene education to improve sleep quality and mood in menopausal women.

The Effect of Information, Motivation, Behavioral Skills (IMB) Model-Based Sleep Hygiene Education on Sleep Quality and Depression Level in Menopausal Women: A Methodological and Experimental Study

Not applicable Interventional Ankara Yildirim Beyazıt University · NCT07299903

This trial will try sleep-hygiene education based on the IMB model to see if it improves sleep quality and reduces depressive symptoms in menopausal women with poor sleep.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment500 (estimated)
Ages45 Years to 60 Years
SexFemale
SponsorAnkara Yildirim Beyazıt University Academic / other
Locations1 site (Ankara)
Trial IDNCT07299903 on ClinicalTrials.gov

What this trial studies

The study first develops a menopause-specific sleep quality scale, then randomizes eligible menopausal women to either an IMB-model sleep-hygiene education program or a control group. The intervention is delivered via online training and participants complete daily sleep logs to monitor adherence. Sleep quality and depressive symptoms are measured before and after the intervention using validated questionnaires and physiologic tracking where applicable. Results will show whether a targeted education program can change sleep behavior and mood in this population.

Who should consider this trial

Good fit: Ideal candidates are women aged 40–60 who are in menopause, have low sleep quality on the menopause-specific scale, can use a smartphone/tablet/computer with internet, and do not have major psychiatric, neurologic, or chronic systemic illnesses or recent sleep-hygiene training.

Not a fit: Patients with diagnosed chronic psychiatric disorders, those currently treated for a sleep disorder, on hormone replacement therapy, with neurologic/systemic conditions affecting sleep, or without internet access are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, the program could provide a low-cost, non-drug way to improve nighttime sleep and reduce depressive symptoms for menopausal women.

How similar studies have performed: Behavioral sleep-hygiene and cognitive-behavioral approaches have shown modest improvements in insomnia symptoms in prior research, but applying the IMB model specifically to menopausal sleep is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being in menopause
* Being between 40 and 60 years of age
* Having a low sleep quality score according to the Menopause-Specific Sleep Quality Scale.
* Being willing to participate in the study.
* Having no physical or mental disabilities that would hinder communication.
* Having technology (smartphone, tablet, or computer) with internet access and the ability to participate in online training.

Exclusion Criteria:

* Having a history of receiving psychological support.
* Having been diagnosed with a chronic psychiatric illness (previously diagnosed depression, anxiety disorder, etc.).
* Having a neurological or chronic systemic illness that may affect sleep quality.
* Being treated for a sleep disorder (receiving medication or psychotherapy).
* Receiving hormone replacement therapy (HT).
* Having received sleep hygiene training/therapy within the last 6 months.

Where this trial is running

Ankara

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions InsomniaDepressive SymptomsMenopauseSleep qualitySleep hygieneDepressionWomen's healthRandomized controlled trial
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.